全文获取类型
收费全文 | 2413篇 |
免费 | 175篇 |
国内免费 | 45篇 |
专业分类
耳鼻咽喉 | 16篇 |
儿科学 | 98篇 |
妇产科学 | 32篇 |
基础医学 | 181篇 |
口腔科学 | 42篇 |
临床医学 | 315篇 |
内科学 | 405篇 |
皮肤病学 | 44篇 |
神经病学 | 102篇 |
特种医学 | 371篇 |
外科学 | 343篇 |
综合类 | 206篇 |
预防医学 | 170篇 |
眼科学 | 20篇 |
药学 | 149篇 |
2篇 | |
中国医学 | 32篇 |
肿瘤学 | 105篇 |
出版年
2022年 | 36篇 |
2021年 | 35篇 |
2020年 | 32篇 |
2019年 | 18篇 |
2018年 | 29篇 |
2017年 | 33篇 |
2016年 | 32篇 |
2015年 | 42篇 |
2014年 | 65篇 |
2013年 | 89篇 |
2012年 | 96篇 |
2011年 | 101篇 |
2010年 | 108篇 |
2009年 | 112篇 |
2008年 | 78篇 |
2007年 | 93篇 |
2006年 | 98篇 |
2005年 | 76篇 |
2004年 | 64篇 |
2003年 | 69篇 |
2002年 | 52篇 |
2001年 | 45篇 |
2000年 | 32篇 |
1999年 | 38篇 |
1998年 | 85篇 |
1997年 | 74篇 |
1996年 | 74篇 |
1995年 | 72篇 |
1994年 | 45篇 |
1993年 | 51篇 |
1992年 | 26篇 |
1991年 | 36篇 |
1990年 | 31篇 |
1989年 | 48篇 |
1988年 | 56篇 |
1987年 | 51篇 |
1986年 | 32篇 |
1985年 | 35篇 |
1984年 | 26篇 |
1983年 | 27篇 |
1982年 | 17篇 |
1980年 | 19篇 |
1977年 | 16篇 |
1963年 | 17篇 |
1959年 | 22篇 |
1958年 | 29篇 |
1957年 | 19篇 |
1956年 | 30篇 |
1955年 | 42篇 |
1954年 | 35篇 |
排序方式: 共有2633条查询结果,搜索用时 31 毫秒
31.
32.
33.
34.
35.
Horne G; Jamaludin A; Critchlow JD; Falconer DA; Newman MC; Oghoetuoma J; Pease EH; Lieberman BA 《Human reproduction (Oxford, England)》1998,13(11):3045-3048
Insemination with donor spermatozoa is an integral part of infertility
treatment. For the last 3 years in our unit, intrauterine insemination with
donor spermatozoa (IUID) has been used in preference to vaginal
insemination. In this retrospective study, patients were offered an initial
course of five single intrauterine inseminations with cryopreserved donor
spermatozoa and treatment was then reviewed. A total of 389 patients
received 1465 inseminations. In all, 1119 cycles were monitored using
luteinizing hormone serum analyses and 346 cycles using the urine home test
kits. The clinical pregnancy rate per insemination for the cycles monitored
by the serum assay was 18.0% (202/1119) compared with the urine cycles
(13.7%, 46/346) (P <05). The pregnancy loss rate was not significantly
different (14.4%, 29/202 and 21.7%, 10/46) (serum and urine cycles
respectively). The viable clinical pregnancy rate was significantly higher
(P <03) for the serum cycles than for the cycles using the urinary
monitoring (15.5%, 173/1119 and 10.4%, 36/346 respectively). The cycles
monitored by serum assay had a significantly higher cumulative viable
clinical pregnancy rate (P <0001) of 70.2% after nine inseminations
compared with the urine monitored cycles of 54.8%. The majority of patients
opted for the serum cycles, with a minority self-selecting the urine cycles
mainly for travelling convenience. The explanation for the significant
differences between the viable clinical pregnancy rates per insemination
and the cumulative viable clinical pregnancy rates may be due to the
sensitivity of the urine home test kit or the patients' interpretation of
the result.
相似文献
36.
Borghouts LB Schaart G Hesselink MK Keizer HA 《Pflügers Archiv : European journal of physiology》2000,441(2-3):351-358
In whole muscle homogenates, the glucose transporter-4 (GLUT-4) content is reported to be higher in muscles consisting predominantly of oxidative (type-1) muscle fibres than in muscles consisting predominantly of glycolytic (type-2) fibres. From these findings, it has been deduced that in rat muscle, oxidative fibres have an intrinsically higher level of GLUT-4 protein than glycolytic fibres. No data is available concerning human muscle. Moreover, the fibre-type-specific expression of GLUT-4 has not yet been examined directly. In this study, the relative abundance of GLUT-4 protein expression in individual fibres of different types within a muscle was compared directly in immunohistochemical assays. The human vastus lateralis muscle and a selection of rat muscles were studied using a novel GLUT-4 antiserum. It is concluded that the pattern of fibre-type-specific GLUT-4 expression differs between human and rats and varies between the different muscles studied, indicating that non-fibre-type-specific factor(s) affect expression of GLUT-4. The observation that within a muscle a fibre-type-specific expression of GLUT-4 was observed indicates that fibre-type-specific factors contribute to GLUT-4 expression as well. Thus, it can be postulated that both fibre-type-dependent and fibre-type-independent factors affect GLUT-4 expression. 相似文献
37.
38.
B lymphocytes secreting IgG linked to latent transforming growth factor- beta prevent primary cytolytic T lymphocyte responses 总被引:3,自引:0,他引:3
B lymphocytes secreting IgG linked to latent transforming growth factor
(TGF)-beta (IgG-TGF-beta) prevent cytolytic T lymphocyte (CTL) responses to
unrelated antigens in mixed lymphocyte cultures (MLC) so long as resting
resident macrophages and functional Fc receptors are present. This was
shown using IgG-secreting plaque-forming cells (PFC) to sheep erythrocytes
(SRBC) obtained from popliteal lymph nodes of mice injected repeatedly in
foot pads with SRBC. Remarkably, as few as approximately 300 PFC prevented
CTL responses of 5 x 10(5) normal syngeneic spleen cells in MLC.
Supranatants of short-term cultures of PFC also prevented CTL responses,
and suppression was prevented by eliminating or dissociating IgG and
TGF-beta present in supranatants or by antibody against active TGF-beta.
Furthermore, the latency- associated peptide of latent TGF-beta was
detected in approximately 10% of foci of IgG captured from single PFC,
indicating that at least some B lymphocytes secrete IgG-TGF-beta as a
complex. Resting resident macrophages (which do not produce latent
TGF-beta) and functional Fc receptors were required for suppression,
consistent with idea that IgG- TGF-beta is taken up through Fc receptors
for IgG and that active TGF- beta, cleaved from latent TGF-beta of the
complex, is delivered directly to potentially responding CTL. If CTL
responses in man are similarly regulated by B lymphocytes, then an ongoing
B cell response in patients with chronic viral infections or bearing
immunogenic cancers may prevent effective therapeutic vaccination.
相似文献
39.
40.
Frank Miedema Pedro A. T. Tetteroo Wim G. Hesselink Guy Werner Hergen Spits Cornelis J. M. Melief 《European journal of immunology》1984,14(6):518-523
A monoclonal antibody, designated CLB-LFA-1/1, directed to the human lymphocyte-function-associated antigen 1 (LFA-1) was raised by immunization of mice with the peripheral blood lymphocytes of a Tγ lymphocytosis patient. The monoclonal antibody was selected by inhibition of the natural killer cell and the antibody-dependent killer cell activity of the patient's Tγ lymphocytes. In addition, the monoclonal antibody was shown to inhibit the cytotoxic activity of T cell clones specific for either class I or class II HLA molecules. The antigen recognized by CLB-LFA-1/1 consisted of three polypeptide chains with molecular weights of 180000 (α), 155000 and 94000 (β). The antibody reacted with T cells, B cells, monocytes and granulocytes, and stained normal Tγ cells and Tγ cells of patients with Tγ lymphocytosis two- to threefold stronger than normal T cells. It was shown that LFA-1 and the Fc receptor on Tγ cells did not comodulate and it is therefore concluded that Fc receptors and LFA-1 are independent membrane structures, both required for the killer cell activity of Tγ cells. 相似文献